Joint (NASDAQ:JYNT) Stock Passes Below 200 Day Moving Average – Time to Sell?

The Joint Corp. (NASDAQ:JYNT)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $8.89 and traded as low as $8.52. Joint shares last traded at $8.58, with a volume of 33,594 shares trading hands.

Analyst Ratings Changes

JYNT has been the subject of several recent analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Joint in a report on Thursday, January 22nd. Zacks Research raised shares of Joint from a “hold” rating to a “strong-buy” rating in a report on Friday, March 13th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $17.00.

Joint Stock Performance

The company has a 50 day simple moving average of $8.97 and a 200 day simple moving average of $8.89. The company has a market capitalization of $121.06 million, a PE ratio of 45.16 and a beta of 1.22.

Joint (NASDAQ:JYNT) last issued its quarterly earnings results on Thursday, March 12th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of $0.05 by $0.02. Joint had a negative return on equity of 1.28% and a net margin of 4.99%.The firm had revenue of $15.17 million during the quarter, compared to analysts’ expectations of $14.12 million. As a group, equities research analysts anticipate that The Joint Corp. will post 0.11 EPS for the current year.

Insider Buying and Selling at Joint

In other Joint news, major shareholder Charles E. Jobson purchased 16,753 shares of the stock in a transaction that occurred on Friday, January 23rd. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $167,530.00. Following the completion of the transaction, the insider owned 1,638,424 shares of the company’s stock, valued at $16,384,240. The trade was a 1.03% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have bought 37,838 shares of company stock valued at $348,886 over the last quarter. Company insiders own 27.90% of the company’s stock.

Institutional Trading of Joint

Hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC increased its holdings in shares of Joint by 17.6% in the second quarter. Geode Capital Management LLC now owns 345,330 shares of the company’s stock valued at $3,986,000 after purchasing an additional 51,704 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Joint by 32.3% during the second quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company’s stock worth $86,000 after buying an additional 1,810 shares during the last quarter. Rhumbline Advisers grew its holdings in Joint by 25.9% in the 2nd quarter. Rhumbline Advisers now owns 20,934 shares of the company’s stock valued at $242,000 after buying an additional 4,307 shares in the last quarter. American Century Companies Inc. grew its holdings in Joint by 13.9% in the 2nd quarter. American Century Companies Inc. now owns 27,572 shares of the company’s stock valued at $318,000 after buying an additional 3,366 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company’s stock worth $95,000 after acquiring an additional 1,698 shares during the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.

About Joint

The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics.